Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010, The Lancet, vol.380, issue.9859, pp.2095-128, 2010. ,
DOI : 10.1016/S0140-6736(12)61728-0
URL : https://hal.archives-ouvertes.fr/hal-00827612
Sexual activity as a risk factor for hepatitis C. Hepatology, 2002. ,
DOI : 10.1053/jhep.2002.36797
Incidence and routes of transmission of hepatitis B virus in France, J.Hepatol, vol.58, issue.1, pp.2003-2011, 2013. ,
Hépatite chronique B : prise en charge, surveillance et traitement. POSTU 2016. 5. World Health Organization, editor. European status report on alcohol and health Copenhagen: World Health Organization, 2010. ,
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study, The Lancet, vol.357, issue.9262, pp.1069-1075, 2001. ,
DOI : 10.1016/S0140-6736(00)04258-6
A novel panel of blood markers to assess the degree of liver fibrosis, Hepatology, vol.39, issue.6, pp.1373-81, 2005. ,
DOI : 10.1016/j.hep.2003.09.022
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis, Ultrasound in Medicine & Biology, vol.29, issue.12, pp.1705-1718, 2003. ,
DOI : 10.1016/j.ultrasmedbio.2003.07.001
Risk factors associated with hepatitis B or C markers or elevated alanine aminotransferase level among blood donors on a tropical island: the Guadeloupe experience, Transfusion, vol.100, issue.8, pp.760-763, 1992. ,
DOI : 10.7326/0003-4819-100-3-339
Seroepidemiology of chronic hepatitis B and C in the French Caribbean Island of Guadeloupe L'hépatite B chronique en Guadeloupe : un profil épidémiologique original, BMC Res Notes, vol.755, issue.11, 2013. ,
Facteurs de progression et évolution des hépatopathies chroniques virales et alcooliques en Guadeloupe, 2015. ,
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C, Journal of Hepatology, vol.34, issue.5, pp.730-739, 2001. ,
DOI : 10.1016/S0168-8278(00)00097-0
Natural history of liver fibrosis progression in patients with chronic hepatitis C. The Lancet, pp.825-857, 1997. ,
Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C - a study of 527 patients at one establishment, Journal of Viral Hepatitis, vol.37, issue.4, pp.268-75, 2000. ,
DOI : 10.1002/hep.510270529
Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection, Journal of Viral Hepatitis, vol.27, issue.3, pp.235-276, 2002. ,
DOI : 10.1002/hep.510260707
Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C, The American Journal of Gastroenterology, vol.25, issue.7, pp.1807-1819, 2002. ,
DOI : 10.1016/S0140-6736(95)91685-7
Sex and hepatic fibrosis, Hepatology, vol.88, issue.3, pp.988-997, 1999. ,
DOI : 10.1002/hep.510290351
Do the epidemiology, physiological mechanisms and characteristics of hepatocellular carcinoma in HIV-infected patients justify specific screening policies?, AIDS, vol.28, issue.10, pp.1379-91, 2014. ,
DOI : 10.1097/QAD.0000000000000300
Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users ,
Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients, Journal of Hepatology, vol.37, issue.6, pp.837-879, 2002. ,
DOI : 10.1016/S0168-8278(02)00299-4
Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data, Liver International, vol.29, pp.13-25, 2009. ,
DOI : 10.1111/j.1478-3231.2008.01952.x
Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut, pp.1003-1011, 2005. ,
Contribution of obesity to hepatitis C-related fibrosis progression, The American Journal of Gastroenterology, vol.45, issue.1, pp.2408-2422, 2002. ,
DOI : 10.1136/gut.48.5.707
Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis, Hepatology, vol.29, issue.4, pp.1215-1224, 1999. ,
DOI : 10.1002/hep.510290401
Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity, Hepatology, vol.33, issue.6, pp.1358-64, 2001. ,
DOI : 10.1053/jhep.2001.24432
Fibrosis and disease progression in hepatitis C. Hepatology, pp.47-56, 2002. ,
DOI : 10.1002/hep.1840360707
Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology, pp.121-126, 2001. ,
DOI : 10.1053/jhep.2001.25385
Impact of smoking on histological liver lesions in chronic hepatitis C. Gut, pp.126-135, 2003. ,
Association of caffeine intake and histological features of chronic hepatitis C, Journal of Hepatology, vol.54, issue.6, pp.1123-1132, 2011. ,
DOI : 10.1016/j.jhep.2010.08.027
Daily Cannabis Use: A Novel Risk Factor of Steatosis Severity in Patients With Chronic Hepatitis C. Gastroenterology, Feb, vol.134, issue.2, pp.432-441, 2008. ,
Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients, Hepatology, vol.12, issue.Suppl 3, 2014. ,
DOI : 10.1016/j.cgh.2013.06.006
Carriers of Inactive Hepatitis B Virus Are Still at Risk for Hepatocellular Carcinoma and Liver-Related Death, Gastroenterology, vol.138, issue.5, pp.1747-54, 2010. ,
DOI : 10.1053/j.gastro.2010.01.042
Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men, Hepatology, vol.84, issue.4, pp.1306-1316, 1999. ,
DOI : 10.1002/hep.510290447
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load, Gastroenterology, vol.130, issue.3, 2006. ,
DOI : 10.1053/j.gastro.2005.11.016
Gender Differences in Pharmacokinetics of Alcohol, Alcoholism: Clinical and Experimental Research, vol.112, issue.4, pp.502-509, 2001. ,
DOI : 10.1300/J251v07n03_21
Pesticide exposure of pregnant women in Guadeloupe: Ability of a food frequency questionnaire to estimate blood concentration of chlordecone, Environ Res, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00517109
Chlordecone exposure and adverse effects in French West Indies populations, Environmental Science and Pollution Research, vol.3, issue.6, pp.3-8, 2016. ,
DOI : 10.1080/15287398409530582
URL : https://hal.archives-ouvertes.fr/hal-01150382
Organochlorine pesticides and liver cancer deaths in the United States, pp.1930-1972, 1977. ,
Viral infections and chemical exposures as risk factors for hepatocellular carcinoma in Vietnam, International Journal of Cancer, vol.51, issue.42, pp.196-201, 1993. ,
DOI : 10.7326/0003-4819-116-2-97
Cancer Mortality and Environmental Exposure to DDE in the United States, Environmental Health Perspectives, vol.108, issue.1, p.1, 2000. ,
DOI : 10.1289/ehp.001081
Distribution and excretion of chlordecone (Kepone) in the rat, Drug Metab Dispos, vol.6, issue.1, pp.91-96, 1978. ,
Carcinogenicity of kepone, Journal of Toxicology and Environmental Health, vol.4, issue.5-6, pp.895-911, 1978. ,
DOI : 10.1016/0048-9697(78)90056-6
Carcinomas and Other Lesions of the Liver in Mice Ingesting Organochlorine Pesticides, Clinical Toxicology, vol.17, issue.2, pp.231-256, 1978. ,
DOI : 10.1084/jem.80.3.231
Chemicals and industrial processes associated with cancer in humans: report of an IARC ad hoc working group which met in Lyon to advise the Director, IARC, on chemicals carcinogenic for humans. Lyon: International Agency for Research on Cancer, pp.15-17, 1979. ,
Potentiation of halomethane hepatotoxicity: Chlordecone and carbon tetrachloride*1, Fundamental and Applied Toxicology, vol.4, issue.3, pp.295-308, 1984. ,
DOI : 10.1016/0272-0590(84)90187-8
Carbon tetrachloride metabolism in partially hepatectomized and sham-operated rats pre-exposed to chlordecone (kepone), Journal of Biochemical Toxicology, vol.9, issue.4, pp.211-220, 1989. ,
DOI : 10.1080/00039896.1964.10663818
Chlordecone potentiates hepatic fibrosis in chronic liver injury induced by carbon tetrachloride in mice Epidemic kepone poisoning in chemical workers, Toxicol Lett Am.J.Epidemiol, vol.107, pp.529-537, 1978. ,
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C, Gastroenterology, vol.128, issue.2, 2005. ,
DOI : 10.1053/j.gastro.2004.11.018
Assessment of cirrhosis and its severity by fibroscan and biochemical markers in alcoholic patients, J Hepatol, 2006. ,
V130nb de tasses/j : de (année)V131????????????? à V132?????????????ou(âge)V133??????? à V134??????? ans V340 Durée : ??????? mois V341??????? années V140Episodes de perte ou gain de poids > 10kg depuis l'âge de 20 ans : oui ????non ???? Si oui, V141poids : ??????? kg, de (année) V142????????????? à V143?????????????ou (âge) V144??????? à V145??????? poids : V146??????? kg, de (année) V147????????????? à V148?????????????ou (âge) V149??????? à V150??????? V163Intervention chirurgicale lourde : oui ??1??non ??0??NSP ??2?? V164date :??/??/??.... V165Spécialité concernée: ????????????????????????????????? ,
id ? V290PNN (/mm 3 ) : ?????????.. normes (UI/l): ????.. date :??, ???????? normes id ? V293ASAT (UI/l): ?????????.. V294normes (UI/l): ????.. date :??/??/??.... id ? V295ALAT (UI/l): ?????????.. V296normes (UI/l): ????.. date :?? ,
?????????? normes (µmol/l):?????? V305Clairance créatinine (ml/min): ???????? date ,
normes (ng/ml):?????? date, ) : ): ?????????.. normes (mUI/ml):?????? date :??/??/??.... id ? ,